1000 Coloplast employees to give Atos flying start in China

On Monday, Coloplast announced the acquisition of Atos Medical for DKK 16bn (USD 2.5bn). The plan now is to grow the Swedish company in a number of global markets, says President and CEO at Coloplast Kristian Villumsen, who highlights the two companies' synergies in China, where Atos has multiple upcoming product launches.

Photo: CHINA DAILY/via REUTERS / X01745

Coloplast's President and CEO Kristian Villumsen eyes global growth opportunities in Atos Medical, which the Danish medtech company has just acquired for DKK 16bn (USD 2.5bn).

Both companies look to benefit from the shared ownership, especially when it comes to the Chinese market, where Atos has a string of upcoming launches.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs